Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Molecular Targeted Therapy

Concept
uri icon
  • Overview
scroll to property group menus

Overview

subject area of

  • A role for rev-erb alpha ligands in the regulation of adipogenesis  Academic Article
  • A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein  Academic Article
  • Autophagy-regulated ROS from xanthine oxidase acts as an early effector for triggering late mitochondria-dependent apoptosis in cathepsin S-targeted tumor cells  Academic Article
  • Beyond the ligand: extracellular and transcellular G protein-coupled receptor complexes in physiology and pharmacology  Academic Article
  • Broad anti-tumor activity of a small molecule that selectively targets the Warburg effect and lipogenesis  Academic Article
  • Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape  Academic Article
  • Chemical approaches to stem cell biology and therapeutics  Academic Article
  • Clinical applications of genome editing to HIV cure  Academic Article
  • Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity  Academic Article
  • Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors  Academic Article
  • Cystic fibrosis in an era of genomically guided therapy  Academic Article
  • Design and discovery of N-(2-Methyl-5 '-morpholino-6 '-((tetrahydro-2H-pyran-4-yl)oxy)- 3,3 '-bipyridin -5-yl)-3-(trifluoromethyl)benzamide (RAF709): a potent, selective, and efficacious RAF inhibitor targeting RAS mutant cancers  Academic Article
  • Designing a broad-spectrum integrative approach for cancer prevention and treatment  Academic Article
  • Determining target engagement in living systems  Academic Article
  • Discovery of novel drugs for promising targets  Academic Article
  • Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition  Academic Article
  • Endocannabinoid regulation of amyloid-induced neuroinflammation  Academic Article
  • Glucokinase activators  Academic Article
  • HIV latency and the noncoding RNA therapeutic landscape  Academic Article
  • How ligands illuminate GPCR molecular pharmacology  Academic Article
  • Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network  Academic Article
  • Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models  Academic Article
  • Inhibition of class i histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue  Academic Article
  • Kinetic analysis of membrane potential dye response to NaV1.7 channel activation identifies antagonists with pharmacological selectivity against NaV1.5  Academic Article
  • Lysophospholipid receptors in drug discovery  Academic Article
  • Mechanisms of drug resistance in kinases  Academic Article
  • Musashi RNA-binding proteins as cancer drivers and novel therapeutic targets  Academic Article
  • NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer  Academic Article
  • Necessity of lysophosphatidic acid receptor 1 for development of arthritis  Academic Article
  • New treatment options for hearing loss  Academic Article
  • Not so pseudo anymore: pseudogenes as therapeutic targets  Academic Article
  • Novel approaches for targeting the adenosine A2A receptor  Academic Article
  • PI3K and STAT3: A new alliance  Academic Article
  • Passenger deletions generate therapeutic vulnerabilities in cancer  Academic Article
  • Patient-derived models of acquired resistance can identify effective drug combinations for cancer  Academic Article
  • Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness  Academic Article
  • Pyrrolidin-3-yl-N-methylbenzamides as potent histamine 3 receptor antagonists  Academic Article
  • RNA structures as mediators of neurological diseases and as drug targets  Academic Article
  • Rational design of chemical genetic probes of RNA function and lead therapeutics targeting repeating transcripts  Academic Article
  • Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics  Academic Article
  • Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies  Academic Article
  • Rho kinase inhibitors: a patent review (2012-2013)  Academic Article
  • Role of corticotropin-releasing factor in drug addiction potential for pharmacological intervention  Academic Article
  • Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions  Academic Article
  • Small molecule targeting of a microRNA associated with hepatocellular carcinoma  Academic Article
  • Structural properties of non-traditional drug targets present new challenges for virtual screening  Academic Article
  • Synthesis and structure-activity relationship of 4-quinolone-3-carboxylic acid based inhibitors of glycogen synthase kinase-3 beta  Academic Article
  • Targeting cancer metabolism to develop human lactate dehydrogenase (hLDH)5 inhibitors  Academic Article
  • Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway  Academic Article
  • Targeting lactate metabolism for cancer therapeutics  Academic Article
  • Targeting malignant B cells with an immunotoxin against ROR1  Academic Article
  • Targeting renal cell carcinoma with a HIF-2 antagonist  Academic Article
  • Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism  Academic Article
  • Targeting unfolded protein response signaling pathways to ameliorate protein misfolding diseases  Academic Article
  • The GPCR Network: a large-scale collaboration to determine human GPCR structure and function  Academic Article
  • The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs  Academic Article
  • The hybrid pyrroloisoindolone-dehydropyrrolizine alkaloid (-)-chlorizidine A targets proteins within the glycolytic pathway  Academic Article
  • The tumor microenvironment: A target for combination therapy of breast cancer  Academic Article
  • Therapeutic targeting of casein kinase 1δ in breast cancer  Academic Article
  • Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy  Academic Article
  • What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands?  Academic Article

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support